Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases. / Hald, Marianne; Arendrup, Maiken C; Svejgaard, Else L; Lindskov, Rune; Foged, Erik K; Saunte, Ditte Marie L; Danish Society of Dermatology.
In: Acta Dermatovenereologica, Vol. 95, No. 1, 2015, p. 12-9.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases
AU - Hald, Marianne
AU - Arendrup, Maiken C
AU - Svejgaard, Else L
AU - Lindskov, Rune
AU - Foged, Erik K
AU - Saunte, Ditte Marie L
AU - Danish Society of Dermatology
PY - 2015
Y1 - 2015
N2 - Internationally approved guidelines for the diagnosis and management of Malassezia-related skin diseases are lacking. Therefore, a panel of experts consisting of dermatologists and a microbiologist under the auspices of the Danish Society of Dermatology undertook a data review and compiled guidelines for the diagnostic procedures and management of pityriasis versicolor, seborrhoeic dermatitis and Malassezia folliculitis. Main recommendations in most cases of pityriasis versicolor and seborrhoeic dermatitis include topical treatment which has been shown to be sufficient. As first choice, treatment should be based on topical antifungal medication. A short course of topical corticosteroid or topical calcineurin inhibitors has an anti-inflammatory effect in seborrhoeic dermatitis. Systemic antifungal therapy may be indicated for widespread lesions or lesions refractory to topical treatment. Maintenance therapy is often necessary to prevent relapses. In the treatment of Malassezia folliculitis systemic antifungal treatment is probably more effective than topical treatment but a combination may be favourable.
AB - Internationally approved guidelines for the diagnosis and management of Malassezia-related skin diseases are lacking. Therefore, a panel of experts consisting of dermatologists and a microbiologist under the auspices of the Danish Society of Dermatology undertook a data review and compiled guidelines for the diagnostic procedures and management of pityriasis versicolor, seborrhoeic dermatitis and Malassezia folliculitis. Main recommendations in most cases of pityriasis versicolor and seborrhoeic dermatitis include topical treatment which has been shown to be sufficient. As first choice, treatment should be based on topical antifungal medication. A short course of topical corticosteroid or topical calcineurin inhibitors has an anti-inflammatory effect in seborrhoeic dermatitis. Systemic antifungal therapy may be indicated for widespread lesions or lesions refractory to topical treatment. Maintenance therapy is often necessary to prevent relapses. In the treatment of Malassezia folliculitis systemic antifungal treatment is probably more effective than topical treatment but a combination may be favourable.
KW - Administration, Cutaneous
KW - Adrenal Cortex Hormones
KW - Anti-Inflammatory Agents
KW - Antifungal Agents
KW - Calcineurin Inhibitors
KW - Dermatitis, Seborrheic
KW - Dermatology
KW - Drug Administration Schedule
KW - Drug Therapy, Combination
KW - Evidence-Based Medicine
KW - Folliculitis
KW - Humans
KW - Malassezia
KW - Time Factors
KW - Tinea Versicolor
KW - Treatment Outcome
U2 - 10.2340/00015555-1825
DO - 10.2340/00015555-1825
M3 - Journal article
C2 - 24556907
VL - 95
SP - 12
EP - 19
JO - Acta Dermato-Venereologica
JF - Acta Dermato-Venereologica
SN - 0001-5555
IS - 1
ER -
ID: 162605270